247 related articles for article (PubMed ID: 19286489)
1. Tongue hyperpigmentation during interferon-alpha and ribavirin therapy.
Aguayo-Leiva I; Pérez B; Salguero I; Jaén P
Eur J Dermatol; 2009; 19(3):291-2. PubMed ID: 19286489
[No Abstract] [Full Text] [Related]
2. Tongue hyperpigmentation during interferon therapy.
Karabay O; Goksugur N; Ogutlu A
J Dermatol; 2011 Mar; 38(3):290-1. PubMed ID: 21342236
[No Abstract] [Full Text] [Related]
3. Tongue hyperpigmentation in a caucasian patient coinfected with HIV and hepatitis C during peginterferon alfa-2b and ribavirin therapy.
Torres HA; Bull L; Arduino RC; Barnett BJ
Am J Gastroenterol; 2007 Jun; 102(6):1334-5. PubMed ID: 17531028
[No Abstract] [Full Text] [Related]
4. What caused this lingual hyperpigmentation in a patient with chronic hepatitis C?
Radha Krishna Y; Itha S
Liver Int; 2010 Mar; 30(3):416. PubMed ID: 19422481
[No Abstract] [Full Text] [Related]
5. [Probable cutaneous sarcoidosis associated with combined ribavirin and interferon-alpha therapy for chronic hepatitis C].
Savoye G; Goria O; Herve S; Riachi G; Noblesse I; Bastien L; Courville P; Lerebours E
Gastroenterol Clin Biol; 2000; 24(6-7):679. PubMed ID: 10962394
[No Abstract] [Full Text] [Related]
6. A surprising hyperpigmentation of the gums and tongue.
Dell'Isola S; Ialungo AM; Starnini G; Roselli P; Ghittoni G; Caturelli E
Gut; 2008 Dec; 57(12):1697, 1727. PubMed ID: 19022927
[No Abstract] [Full Text] [Related]
7. Tongue hyperpigmentation during hepatitis C treatment.
Bachmeyer C; Pellen JC
CMAJ; 2012 Sep; 184(13):1498. PubMed ID: 22451683
[No Abstract] [Full Text] [Related]
8. Interferon plus ribavirin: a cautionary note.
Macedo G; Ribeiro T
Am J Gastroenterol; 1999 Oct; 94(10):3087-8. PubMed ID: 10520894
[No Abstract] [Full Text] [Related]
9. Lingual hyperpigmentation with pegylated interferon and ribavirin therapy in patients with chronic hepatitis C.
Sood A; Midha V; Bansal M; Goyal A; Sharma N
Indian J Gastroenterol; 2006; 25(6):324. PubMed ID: 17264447
[No Abstract] [Full Text] [Related]
10. Oral hyperpigmentation associated with interferon-alpha and ribavirin therapy for hepatitis C virus infection.
Marcoval J; Notario J; Martín C; Gómez S
Actas Dermosifiliogr; 2014 Mar; 105(2):211-2. PubMed ID: 23623282
[No Abstract] [Full Text] [Related]
11. [Lingual hyperpigmentation in a patient with chronic infection].
López Peláez MV; González Díaz P; Téllez Molina MJ; Vergas García J
Enferm Infecc Microbiol Clin; 2013 Apr; 31(4):264-5. PubMed ID: 23260387
[No Abstract] [Full Text] [Related]
12. Face skin hyperpigmentation during pegylated interferon and ribavirin therapy.
Yaşar B; Yaşar Ş; Güneş P
Turk J Gastroenterol; 2015 Mar; 26(2):189-90. PubMed ID: 25835121
[No Abstract] [Full Text] [Related]
13. Combination treatment for hepatitis C can be hazardous in patients co-infected with HIV.
Schvarcz R; Moberg L; Sönnerborg A
Antivir Ther; 1998; 3(4):233-4. PubMed ID: 10682144
[No Abstract] [Full Text] [Related]
14. Interferon-induced haemolytic anaemia in hepatitis C.
Al-Ansari M; Weilert F; Dickson G
N Z Med J; 2008 Jul; 121(1278):78-81. PubMed ID: 18670477
[No Abstract] [Full Text] [Related]
15. Tongue hyperpigmentation resulting from peginterferon alfa and ribavirin combination therapy: a case report.
de Moraes PC; Noce CW; Thomaz LA; Mautoni MC; Corrêa ME
J Am Dent Assoc; 2009 Nov; 140(11):1377-9. PubMed ID: 19884395
[TBL] [Abstract][Full Text] [Related]
16. [The influence of HCV infection and immunomodulating therapy (interferon-alpha and ribavirin) on the condition of minor salivary glands and oral mucosa].
Sulka A; Simon K; Jeleń M; Piszko P
Przegl Epidemiol; 2005; 59(2):455-66. PubMed ID: 16190554
[TBL] [Abstract][Full Text] [Related]
17. Development of Myasthenia gravis due to treatment of chronic hepatitis C with a combination of interferon-alpha and ribavirin.
Bektas M; Bektas H; Gören D; Altan M; Cetinkaya H
Digestion; 2007; 75(4):208-9. PubMed ID: 17934275
[No Abstract] [Full Text] [Related]
18. [Onset of type 1 diabetes mellitus during combination therapy of chronic hepatitis C with interferon-alpha and ribavirin].
Christensen UB; Krogsgaard K
Ugeskr Laeger; 2004 Mar; 166(11):1024-5. PubMed ID: 15049242
[No Abstract] [Full Text] [Related]
19. Hyperpigmentation during interferon-alpha therapy for chronic hepatitis C virus infection.
Willems M; Munte K; Vrolijk JM; Den Hollander JC; Böhm M; Kemmeren MH; De Man RA; Brouwer JT
Br J Dermatol; 2003 Aug; 149(2):390-4. PubMed ID: 12932249
[TBL] [Abstract][Full Text] [Related]
20. Iatrogenic hyperpigmentation in chronically infected hepatitis C patients treated with pegylated interferon and ribavirin.
Lin J; Lott JP; Amorosa VK; Kovarik CL
J Am Acad Dermatol; 2009 May; 60(5):882-3. PubMed ID: 19389538
[No Abstract] [Full Text] [Related]
[Next] [New Search]
